Voyager Therapeutics Inc (NASDAQ:VYGR)
| 11.33 Delayed Data As of 3:59pm ET |  -0.42 / -3.57%Today’s Change | 4.61 Today|||52-Week Range 14.34 | +85.74% Year-to-Date |
Institutional investors purchased a net $1.9 million shares of VYGR during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 45.63% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
| Other institutional | 35.19% |
| Individual stakeholders | 29.55% |
| Mutual fund holders | 10.44% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 3/31/2023 | MILLENNIUM MANAGEMENT LLC Bought 883.9 Thousand shares of Voyager Therapeutics Inc |
| 3/31/2023 | FARALLON CAPITAL MANAGEMENT LLC Bought 797.0 Thousand shares of Voyager Therapeutics Inc |
| 3/31/2023 | SUSQUEHANNA FINANCIAL GROUP LLLP Bought 171.1 Thousand shares of Voyager Therapeutics Inc |
Top 10 Owners of Voyager Therapeutics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 8.90% | 3,851,507 | 27,923,426 | -902,400 | -18.98% |
| Armistice Capital LLC | 8.14% | 3,524,000 | 25,549,000 | +128,000 | +3.77% |
| The Vanguard Group, Inc. | 4.52% | 1,955,193 | 14,175,149 | +9,508 | +0.49% |
| Millennium Management LLC | 2.69% | 1,162,553 | 8,428,509 | +883,899 | +317.20% |
| T. Rowe Price Associates, Inc. (I... | 2.08% | 901,465 | 6,535,621 | +104,144 | +13.06% |
| Farallon Capital Management LLC | 1.84% | 797,000 | 5,778,250 | +797,000 | -- |
| Acadian Asset Management LLC | 1.72% | 742,355 | 5,382,074 | +73,617 | +11.01% |
| BlackRock Fund Advisors | 1.64% | 709,702 | 5,145,340 | -33,693 | -4.53% |
| D. E. Shaw & Co. LP | 1.45% | 628,472 | 4,556,422 | -60,228 | -8.75% |
| Federated MDTA LLC | 1.40% | 605,618 | 4,390,731 | -41 | -0.01% |
Top 10 Mutual Funds Holding Voyager Therapeutics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Vanguard Total Stock Market ETF | 2.23% | 965,990 | 7,003,428 | 0 | 0.00% |
| Vanguard Explorer Fund | 1.06% | 457,063 | 3,313,707 | 0 | 0.00% |
| Vanguard Extended Market Index Fu... | 0.86% | 372,113 | 2,697,819 | 0 | 0.00% |
| JPMorgan Funds - Thematics - Gene... | 0.74% | 321,778 | 2,332,891 | +37,237 | +13.09% |
| Federated Hermes MDT Small Cap Gr... | 0.73% | 313,875 | 2,275,594 | 0 | 0.00% |
| Federated Hermes MDT Small Cap Co... | 0.63% | 274,488 | 1,990,038 | 0 | 0.00% |
| iShares Biotechnology ETF | 0.47% | 204,932 | 1,485,757 | -340 | -0.17% |
| Erste Stock Biotec | 0.44% | 188,900 | 1,369,525 | 0 | 0.00% |
| Fidelity Extended Market Index Fu... | 0.32% | 138,746 | 1,005,909 | 0 | 0.00% |
| Monega ARIAD Innovation | 0.30% | 131,800 | 955,550 | 0 | 0.00% |